Phong Phu Pharmaceutical JSC (HNX:PPP)

HNX:PPP Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	134,983	137,548	152,172	150,575	133,289	116,257
Revenue Growth (YoY)	-2.84%	-9.61%	1.06%	12.97%	14.65%	-23.28%
Cost of Revenue	87,663	91,144	103,016	99,285	88,053	80,245
Gross Profit	47,320	46,404	49,156	51,290	45,237	36,012
Selling, General & Admin	26,875	26,149	26,046	26,096	25,543	23,330
Operating Expenses	26,875	26,149	26,046	26,096	25,543	23,330
Operating Income	20,445	20,255	23,110	25,194	19,693	12,682
Interest Expense	-40.34	-	-	-45.36	-434.42	-1,649
Interest & Investment Income	1,499	1,390	1,327	561.01	109.53	187.27
Currency Exchange Gain (Loss)	-0.96	-0.96	-1.46	-	-	-
Other Non Operating Income (Expenses)	110.66	143.82	150.99	93.21	77.97	332.1
EBT Excluding Unusual Items	22,013	21,788	24,587	25,802	19,446	11,552
Gain (Loss) on Sale of Assets	22.35	22.35	0.94	-	-	-
Pretax Income	22,036	21,810	24,588	25,802	19,446	11,552
Income Tax Expense	4,477	4,451	4,486	5,191	2,553	1,737
Net Income	17,559	17,359	20,102	20,611	16,893	9,815
Preferred Dividends & Other Adjustments	1,812	1,812	1,964	-	-	-
Net Income to Common	15,747	15,548	18,138	20,611	16,893	9,815
Net Income Growth	2.17%	-13.64%	-2.47%	22.01%	72.11%	-19.63%
Shares Outstanding (Basic)	9	9	9	10	10	10
Shares Outstanding (Diluted)	9	9	9	10	10	10
Shares Change (YoY)	-5.15%	-	-9.83%	-0.34%	-0.72%	5.58%
EPS (Basic)	1776.91	1766.77	2061.13	2112.00	1725.00	995.00
EPS (Diluted)	1776.91	1766.77	2061.13	2112.00	1725.00	995.00
EPS Growth	2.46%	-14.28%	-2.41%	22.43%	73.37%	-23.87%
Free Cash Flow	14,510	16,787	17,428	20,117	18,129	9,045
Free Cash Flow Per Share	1637.38	1907.56	1980.47	2061.38	1851.27	916.90
Dividend Per Share	1500.000	1500.000	1200.000	1400.000	-	-
Dividend Growth	25.00%	25.00%	-14.29%	-	-	-
Gross Margin	35.06%	33.74%	32.30%	34.06%	33.94%	30.98%
Operating Margin	15.15%	14.73%	15.19%	16.73%	14.77%	10.91%
Profit Margin	11.67%	11.30%	11.92%	13.69%	12.67%	8.44%
Free Cash Flow Margin	10.75%	12.20%	11.45%	13.36%	13.60%	7.78%
EBITDA	24,469	24,368	27,926	31,419	25,871	18,878
EBITDA Margin	18.13%	17.72%	18.35%	20.87%	19.41%	16.24%
D&A For EBITDA	4,024	4,112	4,816	6,225	6,178	6,196
EBIT	20,445	20,255	23,110	25,194	19,693	12,682
EBIT Margin	15.15%	14.73%	15.19%	16.73%	14.77%	10.91%
Effective Tax Rate	20.32%	20.41%	18.25%	20.12%	13.13%	15.04%
Revenue as Reported	134,983	137,548	152,172	150,575	133,289	116,257
Advertising Expenses	-	490.39	285.73	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.